Skip to main content

Post-IPO Debt Pharmaceutical Companies

Explore 65 pharmaceutical startups that raised post-ipo debt funding. Access verified founder contact information and fundraising data.

Total Companies
65
Total Funding
$12.2B
Avg Funding
$488.8M
Cities
23

Export 65 Post-IPO Debt Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Alpharetta, United States
$3.0M
raised

Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.

Jul 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Mississauga, Canada
$21.7M
raised

TerrAscend is a cannabis company that provides products, brands, and services to the cannabinoid market.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

New York, United States
$250.0M
raised

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Chicago, United States
$50.0M
raised

Cresco Labs is a vertically-integrated multi-state cannabis operator inciting the progressive evolution of the medical cannabis industry.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Uppsala, Sweden
$2.6M
raised

Klaria's business concept is to develop and commercialize innovative products

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 65 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Radnor, United States
$500.0M
raised

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Tampa, United States
$21.0M
raised

Wellgistics Health is a logistic company that focuses on streamlining healthcare technology and pharmaceutical from manufacturer to patient.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Saskatoon, Canada
$505K
raised

ZYUS is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Foster City, United States
$600.0M
raised

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Cranford, United States
$25.0M
raised

Citius Oncology is a pharmaceutical company that provides the development and commercialization of innovative oncology therapies.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 65 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Juan, Puerto Rico
$22.5M
raised

Aspire Biopharma is a biotechnology company that develops nano technology drug formulation technology and medicinal products.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Pickering, Canada
$1.4M
raised

Ayurcann provides production services in extraction, processing, packaging, and distribution.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Farmington Hills, United States
$35.0M
raised

Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ørsta, Norway
$1.5M
raised

Arctic Bioscience is a biotech company that produces bioactive marine-based pharmaceutical and nutraceutical products and solutions.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Foster City, United States
$2.0M
raised

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 65 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Calabasas, United States
$7.0M
raised

Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

La Jolla, United States
$75.0M
raised

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Mölndal, Sweden
$9.2M
raised

Cinclus Pharma is a research based biotech company.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Richmond, United States
$450.0M
raised

Indivior is a specialty pharmaceuticals business.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

North Chicago, United States
$8.0B
raised

AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics.

Feb 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 65 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Smiths Falls, Canada
$147.9M
raised

Canopy Growth is a cannabis consumer product company that manufactures medical cannabis to improve lives.

Jan 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Boucherville, Canada
$8.7M
raised

LSL Pharma Group is a manufacturing company that innovates and manufactures life sciences products.

Dec 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Parsippany, United States
$1.8B
raised

Zoetis is an animal health company that advances care for animals and supports their health and wellbeing.

Dec 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Quincy, United States
$200.0M
raised

Trulieve is a pharmaceutical company that manufactures integrated seed-to-sale medical cannabis products for brain and health treatments.

Dec 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Mölndal, Sweden
$37.0M
raised

Cereno Scientific develops therapies for cardiovascular diseases using epigenetic modulation and advances drug candidates like CS1.

Nov 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 65 companies

Ready to Connect with Post-IPO Debt Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 65 post-ipo debt pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked